Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 1, 2000

View Archived Issues

Italian Firm Novuspharma Seeks EUR177.3M In Combined Offering

Amrad Cutting Back Operations To Focus On Research Portfolio

European Scientists To Convene On Use Of Genomic Information

Fallout From Cantab Setback Continues With CEO Departure

European Commission Prepares Criteria For GMM Contained Use

Astex Signs Deal With Janssen, Plans Second Funding Round

CAT, HGS Extend Collaboration To Develop Antibodies For BLyS

Industry Seeks Change Of Focus From National To European Level

Jump In Genset's Quarterly Loss Linked To New Corporate Strategy

Medarex Increases IDM Stake Through Licensing Agreement

Uroghne Enters Research Deal, Closes Its First Funding Round

MediGene and Schering Move Cancer Vaccine Into Phase I/II

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...